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Introduction: Until recently, aortic stenosis (AS) has been considered as a passive 
process secondary to calcium deposit in the aortic valves. However, lately several 
authors have pointed out that risk factors associated with the development of calcified 
AS in the elderly are similar to those of coronary artery disease. Furthermore, some 
studies have demonstrated that degenerative AS shares histological findings with 
atherosclerotic plaques which have led to the suggestion that calcified aortic valve 
disease is a chronic inflammatory process similar to atherosclerosis. Nevertheless, exist 
discordant data with this theory and it is necessary to study this pathology
The aim of this study is to obtain the aortic stenosis valves proteomic profile and in addition, 
the identification of new biomarker diagnosis and prognosis and/or therapeutic target.
Methods: AS valves obtained from necropsies (control samples) or by surgery 
patients were homogenized in extraction protein buffer. Both samples were analyzed 
using 2D-DIGE and LC-MS/MS. Furthermore, AS and control leaflets were studied 
by immunohystochemical (IH) and Western blot (WB) analysis, using a panel of 
monoclonal antibodies specifics for inflammatory and cytoskeletal/contractile proteins. 
The proteomic results were confirmed by WB and IH.
Results: 10 patients underwent aortic valve replacement due to severe stenosis 
with calcification of the leaflets, were compared with 10 control valves obtained by 
necropsies. The result of 2D-DIGE analysis of the proteome of AS valves compared 
with control valves reveals the expression protein alteration in several proteins such as 
27 Heat shockprotein, osteopontin, vimentin.
To confirm the proteomic results several proteins were analyzed by Western blot 
and IH techniques. Furthermore, we have characterized the cellular composition 
of degenerative aortic stenotic valves by IH. The fibrosa layer of AVL had a higher 
cellularity than spongiosa and ventricularis (elastic) and it was the principal layer which 
was damaged in the lesion.
